Atlas Funds Management

Why picking ASX biotechs is mostly for the crazy brave

Why picking ASX biotechs is mostly for the crazy brave

It’s a space with a reputation for rollercoaster returns and outlandish sales pitches, but some investors get lucky.

Exit mobile version